Back to Search Start Over

The importance of oxidative biomarkers in diagnosis, treatment, and monitoring schizophrenia patients.

Authors :
Cecerska-Heryć E
Polikowska A
Serwin N
Michalczyk A
Stodolak P
Goszka M
Zoń M
Budkowska M
Tyburski E
Podwalski P
Waszczuk K
Rudkowski K
Kucharska-Mazur J
Mak M
Samochowiec A
Misiak B
Sagan L
Samochowiec J
Dołęgowska B
Source :
Schizophrenia research [Schizophr Res] 2024 Aug; Vol. 270, pp. 44-56. Date of Electronic Publication: 2024 Jun 08.
Publication Year :
2024

Abstract

Introduction: The etiology of schizophrenia (SCZ), an incredibly complex disorder, remains multifaceted. Literature suggests the involvement of oxidative stress (OS) in the pathophysiology of SCZ.<br />Objectives: Determination of selected OS markers and brain-derived neurotrophic factor (BDNF) in patients with chronic SCZ and those in states predisposing to SCZ-first episode psychosis (FP) and ultra-high risk (UHR).<br />Materials and Methods: Determination of OS markers and BDNF levels by spectrophotometric methods and ELISA in 150 individuals (116 patients diagnosed with SCZ or in a predisposed state, divided into four subgroups according to the type of disorder: deficit schizophrenia, non-deficit schizophrenia, FP, UHR). The control group included 34 healthy volunteers.<br />Results: Lower activities of analyzed antioxidant enzymes and GSH and TAC concentrations were found in all individuals in the study group compared to controls (p < 0.001). BDNF concentration was also lower in all groups compared to controls except in the UHR subgroup (p = 0.01). Correlations were observed between BDNF, R-GSSG, GST, GPx activity, and disease duration (p < 0.02). A small effect of smoking on selected OS markers was also noted (rho<0.06, p < 0.03).<br />Conclusions: OS may play an important role in the pathophysiology of SCZ before developing the complete clinical pattern of the disorder. The redox imbalance manifests itself with such severity in individuals with SCZ and in a state predisposing to the development of this psychiatric disease that natural antioxidant systems become insufficient to compensate against it completely. The discussed OS biomarkers may support the SCZ diagnosis and predict its progression.<br />Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.<br /> (Copyright © 2024 Elsevier B.V. All rights reserved.)

Details

Language :
English
ISSN :
1573-2509
Volume :
270
Database :
MEDLINE
Journal :
Schizophrenia research
Publication Type :
Academic Journal
Accession number :
38851167
Full Text :
https://doi.org/10.1016/j.schres.2024.05.018